Maksim (Max) Royzen research into applications of bio-orthogonal chemistry for in vivo imaging and RNA synthesis.
Maksim Royzen, Max Royzen, RNA imaging, live cell imaging, TCO, tetrazine, trans-cyclooctene, UAlbany Chemistry, RNA Institute, bio-orthogonal, bioorthogonal, MNP, nanoparticle, HMT, hydrogel, soft tissue sarcoma, STS, doxorubicin, dox-TCO, RNA-protein interactions, PRE, paramagnetic NMR, RNA synthesis, drug delivery
page-template-default,page,page-id-15188,bridge-core-2.0.9,ajax_fade,page_not_loaded,,qode-title-hidden,transparent_content,qode-theme-ver-19.6,qode-theme-bridge,disabled_footer_bottom,qode_header_in_grid,wpb-js-composer js-comp-ver-6.1,vc_responsive


23 DECEMBER 2020

Royzen Lab has recently been in the news that highlight our collaboration with a San Francisco start-up Shasqi, Inc. Our collaboration resulted in a development of a Click Activated Protodrugs Against Cancer (CAPAC) platform, which is currently being evaluated in Phase I clinical trials for the treatment of advanced solid tumors.

C&E News Article

UAlbany Article

UC Davis Article

15 DECEMBER 2020

Congratulations to Muhan He who successfully defended her PhD dissertation, titled: Development of chemical methods for oligonucleotide purification, paramagnetic labeling and synthesis of DNA-based advanced materials. Muhan’s most recent work, describing non-chromatographic purification of synthetic RNA has been uploaded to bioRxiv.


Our collaborative work with Shasqi, Inc. resulted in two publications which have been uploaded to bioRxiv and ChemRxiv. These manuscripts are currently undergoing peer review. These papers were recently discussed in a Science Translational Medicine Blog.

bioRxiv manuscript

ChemRxiv manuscript

3 APRIL 2020

Our collaborative work with Lei Zhu Lab (FSU) was just accepted for publication in Bioconjugate Chemistry. Our publication describes in-cell labeling of proteins of interest using two orthogonal bio-orthogonal chemistries. Congratulations to everyone who contributed to this work.

26 MARCH 2020

Our collaborative work with Yigit Lab was just accepted for publication in ChemMedChem. The paper describes spectroscopic analysis of in-cell activation of doxorubicin. This work is supported by our collaborative R15 grant from NIGMS.

15 FEBRUARY 2020

Our long awaited book chapter, titled: “In vivo bioconjugation using bio-orthogonal chemistry” has been published by Wiley. We would like to thank all the contributors.

12 JANUARY 2020

Max Royzen has been promoted to Associate Professor! Thank you to all the colleagues, administrators, and group members past and present, who contributed to Prof. Royzen’s promotion.


After numerous updates and revisions, we finally published a Chem Comm paper describing imaging of ribosomal RNA in live mammalian cells. This work was started by Papa Nii six years ago, continued by Irfan and finished by Muhan And Kui. Congratulations to all the co-authors!


We welcome a new graduate student, Amir Agharezaee, who just joined the Royzen research group with a background in biochemistry. He’ll be working on RNA imaging in live cells.


Our collaborative work with Shasqi, Inc., as well as collaborators from Berlin has just been accepted for publication by ACS Central Science. Congratulations to Eddie, Chris, Hasina, Ilenis and Dr. Khan!


We received another collaborative SBIR grant with Shasqi, Inc. We would like to thank the NIGMS institute of the NIH for their generous support. This will be a 3-year grant focused on the development of bio-orthogonal chemistry-based drug delivery strategies.


We welcome the new postdoctoral scientist, Xunshen Wu, who just joined the Royzen research group from China. Dr. Wu completed his doctoral work past summer at the East China University of Science and Technology.